Federal regulators expanded COVID-19 booster options this week to include the Moderna and Janssen vaccines and allowed eligible people to receive a different brand from the one they originally received.
The FDA’s action covers qualifying Moderna recipients at least six months after their primary series and adult Janssen recipients at least two months after their initial shot. Eligibility depends on the vaccine received and the recipient’s age or risk group.
The decision gives vaccination providers more flexibility when arranging appointments. It follows September’s authorization of a Pfizer booster for certain groups.
Reporting source. Cover photograph: U.S. Food and Drug Administration, public domain.